<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04509063</url>
  </required_header>
  <id_info>
    <org_study_id>2016-051-000001, 1835</org_study_id>
    <nct_id>NCT04509063</nct_id>
  </id_info>
  <brief_title>Investigating Public Enthusiasm for Mammography Screening in Denmark</brief_title>
  <official_title>Investigating Public Enthusiasm for Mammography Screening in Denmark</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Based on an American study by Scherer et al., it is hypothesized that some women will make&#xD;
      irrational choices regarding their participation in mammography screening. Therefore, the aim&#xD;
      is to estimate the prevalence of Danish women having an irrational preference for mammography&#xD;
      screening even when it confers no benefits, but only harms.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prevalence of women making an irrational decision will be compared to the participation&#xD;
      rate in the Danish screening program. The study population will consist of a random sample of&#xD;
      women aged 44-49. Similar to the American study, two types of information will be compared&#xD;
      (detailed vs. non-detailed information about the harms of screening). Participants will be&#xD;
      randomised to one of two information groups. Based on the American study, it is assumed that&#xD;
      the willingness to participate in the hypothetical screening program will be 40 percent. To&#xD;
      achieve the desired precision in this study, a standard error of 2.5 percent is required&#xD;
      corresponding to a confidence interval spanning approximately 35-45 percent. This will&#xD;
      require 384 women in each group, corresponding to a total study population of 768. The survey&#xD;
      will be sent electronically (using &quot;e-Boks&quot;) with a link to access the online survey trial.&#xD;
      The survey will consist of screening and cancer related questions as well as questions on&#xD;
      age, education, and health literacy. Five questions on appraisal of health information from&#xD;
      the Health Literacy Questionnaire will also be included. After the data collection, data will&#xD;
      be linked to data on income, residence, civil status, education, breast cancer diagnosis, and&#xD;
      information on whether a participant is immigrant, descendent or of Danish origin.&#xD;
&#xD;
      The original plan for the main analysis was to compare the two groups of women randomized to&#xD;
      different information groups (detailed vs. non-detailed information about the harms of&#xD;
      screening). However, due to lower participation rate and therefore smaller sample size than&#xD;
      expected, information group was disregarded in the main analysis. The two groups will still&#xD;
      be compared in a secondary analysis. This decision was made before getting access to data&#xD;
      from the questionnaire.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 6, 2020</start_date>
  <completion_date type="Actual">January 4, 2021</completion_date>
  <primary_completion_date type="Actual">January 4, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>Self administered questionnaire</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Irrational preference</measure>
    <time_frame>The outcome is assessed when women answer the questionnaire which is sent out at the same time to all women. The invited women will have 2 months to answer the questionnaire (it should only take around 15 minutes to answer). Planned from November 2020.</time_frame>
    <description>Willingness to participate in mammography screening with no benefits on morbidity or mortality, only harms. Investigated by sending out questionnaire once to all women.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">768</enrollment>
  <condition>Breast Neoplasm Female</condition>
  <condition>Mammography Screening</condition>
  <condition>Decision Making</condition>
  <condition>Information Seeking Behavior</condition>
  <arm_group>
    <arm_group_label>Detailed information about screening harms</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-detailed information about screening harms</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Information about hypothetical mammography screening without benefits</intervention_name>
    <description>We will present an online questionnaire with two types of information on the harms of screening. Then we will compare the prevalence of irrational decisions in the two arms.</description>
    <arm_group_label>Detailed information about screening harms</arm_group_label>
    <arm_group_label>Non-detailed information about screening harms</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Residence: Central Denmark Region&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>44 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Public Health, Aarhus University</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Scherer LD, Valentine KD, Patel N, Baker SG, Fagerlin A. A bias for action in cancer screening? J Exp Psychol Appl. 2019 Jun;25(2):149-161. doi: 10.1037/xap0000177. Epub 2018 Jul 19.</citation>
    <PMID>30024212</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>June 29, 2020</study_first_submitted>
  <study_first_submitted_qc>August 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 11, 2020</study_first_posted>
  <last_update_submitted>January 11, 2021</last_update_submitted>
  <last_update_submitted_qc>January 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breast cancer</keyword>
  <keyword>Mammography screening</keyword>
  <keyword>Decision Making</keyword>
  <keyword>Information Seeking Behavior</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Not allowed by authorities.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 11, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/63/NCT04509063/SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

